Ownership history in Frazier Life Sciences Management, L.P. · 5 quarters on record
This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in DYNE THERAPEUTICS INC (DYN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 3,153,082 | +434,977 | +16.0% | 1.66% | $61.7M | $19.56 |
| 2025 Q3 | ADDED | 2,718,105 | +1,212,121 | +80.5% | 1.03% | $34.4M | $12.65 |
| 2025 Q2 | ADDED | 1,505,984 | +62,643 | +4.3% | 0.57% | $14.3M | $9.52 |
| 2025 Q1 | ADDED | 1,443,341 | +258,501 | +21.8% | 0.69% | $15.1M | $10.46 |
| 2023 Q4 | INITIATED | 1,184,840 | — | — | 0.84% | $15.8M | — |
As of 2025 Q4 — sorted by position size